156.3 🩺 內科專科考前版

156.3.0.1 1⃣ 為䜕 Listeria Important?

  • Mortality 高 (~ 20-30% 老人, ~ 50% 新生兒)
  • Empirical meningitis 必須 cover (幎霡 + 免疫 risk)
  • 食源 outbreak 持續 (2011 cantaloupe 33æ­», 2024 deli/玉米/cookies)

156.3.0.2 2⃣ Meningitis Empirical Algorithm

Age / Risk Empirical Cocktail
< 1 mo Amp + cefotaxime/gentamicin
1 mo - 50 yr healthy Vanco + ceftriaxone ± dex
> 50 yr / 免疫䜎䞋 / EtOH Vanco + ceftriaxone + AMPICILLIN ± dex
Post-NSGY Vanco + cefepime/meropenem

156.3.0.3 3⃣ Rhombencephalitis

  • Listeria 特色 (brainstem; 鑑別 Bickerstaff brainstem encephalitis, TB)
  • Sx: cranial neuropathy + cerebellar ataxia + altered mentation
  • MRI: brainstem T2 ↑
  • LP: 可正垞 protein/glucose 䜆 CSF cx +
  • 治療 longer (21-28d)

156.3.0.4 4⃣ Pregnancy

  • 通報 Public Health
  • Amp ASAP (即䜿懷疑 — 因 culture 慢)
  • Bridge with TMP-SMX 圚 1st/3rd trimester 避免 (folate, kernicterus)
  • Postpartum 治療 mother + 新生兒 (即䜿 asymptomatic, sepsis workup)

156.3.0.5 5⃣ Cephalosporin Intrinsic R

  • PBP3 affinity 䜎
  • 經驗匏 meningitis empirical 必加 amp (≥ 50 或 risk)
  • 侍甹 ceftriaxone monotherapy

156.3.0.6 6⃣ Outbreak Investigation

  • PFGE / WGS — 連結 cases to source food
  • CDC PulseNet system
  • Recall + 食品安党 review

156.3.0.7 7⃣ TMP-SMX in PCN-allergy

  • 5 mg/kg of TMP component q6h IV
  • BBB penetration 䜳
  • Synergy maintained vs amp + gent